| Pharmaceutical active ingredients: |
| Sulfasalazine |
| Available forms, composition and doses of Azulfidine: |
| Suspension; Oral; Sulfasalazine 250 mg / 5 mlTablets; Oral; Sulfasalazine 500 mg |
| Azulfidine medical category: |
| Human:Disease-modifying anti-rheumatic drugs (DMARDs)GIT regulators, antiflatulents and anti-inflammatoriesSulfonamides |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07EC01 - Sulfasalazine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerSanten Pharmaceutical |
| Related documents and information about Azulfidine: |
| Azulfidine prescribing information (PDF) |